Literature DB >> 20869205

The role of hyperglycemia in acute illness: supporting evidence and its limitations.

Sarah Dawn Corathers1, Mercedes Falciglia.   

Abstract

Hyperglycemia is common in acutely ill hospitalized patients and has been linked to poor outcomes, independent of pre-existing diabetes. Correction of hyperglycemia has been shown to decrease morbidity and mortality; however, establishing evidence-based guidelines has been challenging because insulin intervention studies have varied in the questions they have addressed, glucose levels studied, feeding regimen, and quality of methodology. This article reviews the findings and limitations of recent intervention studies that have addressed treatment of inpatient hyperglycemia with intravenous insulin infusion therapy. Discussion of underlying causes of hospital-related hyperglycemia and mechanisms explaining the deleterious effects of hyperglycemia and improved outcomes with insulin intervention are described. Current guidelines from various professional organizations recommend treatment of inpatient hyperglycemia, although exact glycemic targets and identification of which patient subsets will receive greatest benefit from glucose lowering remain an area of ongoing research.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869205     DOI: 10.1016/j.nut.2010.07.013

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

Review 1.  Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

2.  Acute Hepatic Insulin Resistance Contributes to Hyperglycemia in Rats Following Myocardial Infarction.

Authors:  Jiali Wang; Baoshan Liu; Hui Han; Qiuhuan Yuan; Mengyang Xue; Feng Xu; Yuguo Chen
Journal:  Mol Med       Date:  2015-02-23       Impact factor: 6.354

3.  Predictive value of admission glycemia in diabetics with pulmonary embolism compared to non-diabetic patients.

Authors:  Ljiljana Jovanovic; Milena Rajkovic; Vesna Subota; Bojana Subotic; Boris Dzudovic; Jovan Matijasevic; Marija Benic; Sonja Salinger; Stefan Simovic; Vladimir Miloradovic; Tamara Preradovic Kovacevic; Ljiljana Kos; Aleksandar Neskovic; Srdjan Kafedzic; Natasa Markovic Nikolic; Bjanka Bozovic; Nebojsa Bulatovic; Slobodan Obradovic
Journal:  Acta Diabetol       Date:  2022-01-30       Impact factor: 4.280

Review 4.  Safety of Nanoparticles in Medicine.

Authors:  Joy Wolfram; Motao Zhu; Yong Yang; Jianliang Shen; Emanuela Gentile; Donatella Paolino; Massimo Fresta; Guangjun Nie; Chunying Chen; Haifa Shen; Mauro Ferrari; Yuliang Zhao
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

5.  Predictive modeling of morbidity and mortality in COVID-19 hospitalized patients and its clinical implications.

Authors:  Joshua M Wang; Wenke Liu; Xiaoshan Chen; Michael P McRae; John T McDevitt; David Fenyö
Journal:  medRxiv       Date:  2021-03-29

6.  Parenteral nutrition-associated hyperglycemia in non-critically ill inpatients increases the risk of in-hospital mortality (multicenter study).

Authors:  Gabriel Olveira; María José Tapia; Julia Ocón; Carmen Cabrejas-Gómez; María D Ballesteros-Pomar; Alfonso Vidal-Casariego; Carmen Arraiza-Irigoyen; Josefina Olivares; Maria Del Carmen Conde-García; Alvaro García-Manzanares; Francisco Botella-Romero; Rosa P Quílez-Toboso; Lucio Cabrerizo; Pilar Matia; Luisa Chicharro; Rosa Burgos; Pedro Pujante; Mercedes Ferrer; Ana Zugasti; Javier Prieto; Marta Diéguez; María José Carrera; Anna Vila-Bundo; Juan Ramón Urgelés; Carmen Aragón-Valera; Adela Rovira; Irene Bretón; Pilar García-Peris; Araceli Muñoz-Garach; Efren Márquez; Dolores Del Olmo; José Luis Pereira; María C Tous
Journal:  Diabetes Care       Date:  2012-12-06       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.